NotSure2, I don’t agree with your timeline or “analysis.” I think there are many reasons to believe, (and I’m on record as saying) that it’s very likely that Northwest Bio is in the “rolling review” process. So I think once the application is accepted, it will be approved within the 100-day review timeframe. I understand that it could take up to 150 days with the clock-off period, but it appears to me that Northwest Bio is taking the time on the front end, and filing a very complete application, to ensure that there won’t be “requests for further information” so the application can be approved more rapidly.
Any ideas about the number of modules referenced on the MHRA page (5 or so?) vs LG’s mentioning 27 (you may recall that I’d mentioned the number being something around 29ish before back in Dec 22?). Anyhow… just wondering about that module number and the mention of developing a pathway for personalised vaccines that I’d referenced earlier in a reply to you.